Page last updated: 2024-08-16

technetium tc 99m sestamibi and Low Bone Density

technetium tc 99m sestamibi has been researched along with Low Bone Density in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Q; Zhao, Y1
Dong, F; Jia, Q; Meng, Z; Tan, J; Zhang, F; Zhang, M1
Antón, A; Caballero, O; Martínez, A; Serrano, J; Verdú, J1
Udelsman, R1

Reviews

1 review(s) available for technetium tc 99m sestamibi and Low Bone Density

ArticleYear
Primary hyperparathyroidism.
    Current treatment options in oncology, 2001, Volume: 2, Issue:4

    Topics: Adenocarcinoma; Adenoma; Bone Diseases, Metabolic; Calcitonin; Diagnostic Imaging; Diphosphonates; Diuretics; Feedback; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism; Hyperplasia; Kidney; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Phosphates; Radiopharmaceuticals; Surgery, Computer-Assisted; Technetium Tc 99m Sestamibi

2001

Other Studies

3 other study(ies) available for technetium tc 99m sestamibi and Low Bone Density

ArticleYear
Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism.
    Annals of nuclear medicine, 2014, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Blood Chemical Analysis; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging; Young Adult

2014
Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
    Clinical nuclear medicine, 2009, Volume: 34, Issue:7

    Topics: Aged; Bone Diseases, Metabolic; Calcium; Carcinoma; Humans; Male; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi

2009
[Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
    Revista espanola de medicina nuclear, 1998, Volume: 17, Issue:1

    Topics: Bone and Bones; Bone Diseases, Metabolic; Carcinoma; Contrast Media; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Time Factors

1998